Table of Contents

Pharmaceuticals, Volume 3, Issue 4 (April 2010), Pages 782-1285

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Readerexternal link to open them.
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-24

Research

Jump to: Review

p. 782-794
by  and
Pharmaceuticals 2010, 3(4), 782-794; doi:10.3390/ph3040782
Received: 18 January 2010; in revised form: 9 March 2010 / Accepted: 22 March 2010 / Published: 24 March 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (125 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Personalized Medicine)
p. 1045-1062
by , , ,  and
Pharmaceuticals 2010, 3(4), 1045-1062; doi:10.3390/ph3041045
Received: 22 December 2009; in revised form: 23 March 2010 / Accepted: 29 March 2010 / Published: 30 March 2010
Show/Hide Abstract | Cited by 5 | PDF Full-text (399 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Cell-penetrating Peptides)
p. 1063-1069
by , , , , , , , , ,  and
Pharmaceuticals 2010, 3(4), 1063-1069; doi:10.3390/ph3041063
Received: 21 December 2009; in revised form: 5 January 2010 / Accepted: 29 March 2010 / Published: 31 March 2010
Show/Hide Abstract | Cited by 1 | PDF Full-text (207 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Asymmetric Synthesis and Medicinal Chemistry)
abstract graphic
p. 1070-1083
by  and
Pharmaceuticals 2010, 3(4), 1070-1083; doi:10.3390/ph3041070
Received: 17 December 2009; in revised form: 22 March 2010 / Accepted: 1 April 2010 / Published: 1 April 2010
Show/Hide Abstract | PDF Full-text (153 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antibiotics)
p. 1093-1107
by , , ,  and
Pharmaceuticals 2010, 3(4), 1093-1107; doi:10.3390/ph3041093
Received: 18 March 2010; Accepted: 11 April 2010 / Published: 13 April 2010
Show/Hide Abstract | Cited by 5 | PDF Full-text (1216 KB) | HTML Full-text | XML Full-text | Supplementary Files
(This article belongs to the Special Issue Cell-penetrating Peptides)
abstract graphic
p. 1108-1121
by
Pharmaceuticals 2010, 3(4), 1108-1121; doi:10.3390/ph3041108
Received: 25 January 2010; in revised form: 19 March 2010 / Accepted: 1 April 2010 / Published: 14 April 2010
Show/Hide Abstract | PDF Full-text (244 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Interferons)
p. 1232-1240
by , ,  and
Pharmaceuticals 2010, 3(4), 1232-1240; doi:10.3390/ph3041232
Received: 11 February 2010; in revised form: 16 April 2010 / Accepted: 21 April 2010 / Published: 23 April 2010
Show/Hide Abstract | PDF Full-text (640 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Cell-penetrating Peptides)
abstract graphic
p. 1279-1285
by , ,  and
Pharmaceuticals 2010, 3(4), 1279-1285; doi:10.3390/ph3041279
Received: 5 February 2010; in revised form: 14 April 2010 / Accepted: 19 April 2010 / Published: 26 April 2010
Show/Hide Abstract | PDF Full-text (42 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Non-Steroidal Anti-Inflammatory Drugs)

Review

Jump to: Research

p. 795-809
by , ,  and
Pharmaceuticals 2010, 3(4), 795-809; doi:10.3390/ph3040795
Received: 5 February 2010; in revised form: 24 March 2010 / Accepted: 24 March 2010 / Published: 25 March 2010
Show/Hide Abstract | Cited by 1 | PDF Full-text (1337 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Interferons)
abstract graphic
p. 810-838
by  and
Pharmaceuticals 2010, 3(4), 810-838; doi:10.3390/ph3040810
Received: 1 February 2010; in revised form: 15 March 2010 / Accepted: 19 March 2010 / Published: 25 March 2010
Show/Hide Abstract | Cited by 29 | PDF Full-text (638 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Tropical Medicine)
abstract graphic
p. 839-915
by
Pharmaceuticals 2010, 3(4), 839-915; doi:10.3390/ph3040839
Received: 31 December 2009; in revised form: 22 March 2010 / Accepted: 23 March 2010 / Published: 25 March 2010
Show/Hide Abstract | Cited by 29 | PDF Full-text (810 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Mitochondrial Drugs for Neurodegenerative Diseases)
p. 916-939
by ,  and
Pharmaceuticals 2010, 3(4), 916-939; doi:10.3390/ph3040916
Received: 5 January 2010; in revised form: 4 March 2010 / Accepted: 18 March 2010 / Published: 26 March 2010
Show/Hide Abstract | Cited by 1 | PDF Full-text (206 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antihypertensive Drugs)
p. 940-960
by
Pharmaceuticals 2010, 3(4), 940-960; doi:10.3390/ph3040940
Received: 22 December 2009; in revised form: 25 February 2010 / Accepted: 8 March 2010 / Published: 29 March 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (98 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antihypertensive Drugs)
abstract graphic
p. 961-993
by , ,  and
Pharmaceuticals 2010, 3(4), 961-993; doi:10.3390/ph3040961
Received: 22 December 2009; in revised form: 20 February 2010 / Accepted: 29 March 2010 / Published: 30 March 2010
Show/Hide Abstract | Cited by 49 | PDF Full-text (330 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Cell-penetrating Peptides)
p. 994-1015
by , , ,  and
Pharmaceuticals 2010, 3(4), 994-1015; doi:10.3390/ph3040994
Received: 2 March 2010; in revised form: 15 March 2010 / Accepted: 29 March 2010 / Published: 30 March 2010
Show/Hide Abstract | Cited by 19 | PDF Full-text (588 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Interferons)
p. 1016-1044
by , ,  and
Pharmaceuticals 2010, 3(4), 1016-1044; doi:10.3390/ph3041016
Received: 2 February 2010; in revised form: 15 March 2010 / Accepted: 26 March 2010 / Published: 30 March 2010
Show/Hide Abstract | Cited by 2 | PDF Full-text (1162 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antiasthmatic Drugs)
p. 1084-1092
by  and
Pharmaceuticals 2010, 3(4), 1084-1092; doi:10.3390/ph3041084
Received: 13 January 2010; in revised form: 1 April 2010 / Accepted: 9 April 2010 / Published: 12 April 2010
Show/Hide Abstract | Cited by 2 | PDF Full-text (155 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Non-Steroidal Anti-Inflammatory Drugs)
p. 1122-1138
by  and
Pharmaceuticals 2010, 3(4), 1122-1138; doi:10.3390/ph3041122
Received: 30 December 2009; in revised form: 12 March 2010 / Accepted: 9 April 2010 / Published: 15 April 2010
Show/Hide Abstract | Cited by 5 | PDF Full-text (241 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Personalized Medicine)
p. 1139-1161
by ,  and
Pharmaceuticals 2010, 3(4), 1139-1161; doi:10.3390/ph3041139
Received: 24 March 2010; in revised form: 8 April 2010 / Accepted: 14 April 2010 / Published: 19 April 2010
Show/Hide Abstract | Cited by 12 | PDF Full-text (439 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antibiotics)
abstract graphic
p. 1162-1186
by  and
Pharmaceuticals 2010, 3(4), 1162-1186; doi:10.3390/ph3041162
Received: 9 March 2010; in revised form: 3 April 2010 / Accepted: 12 April 2010 / Published: 20 April 2010
Show/Hide Abstract | Cited by 5 | PDF Full-text (203 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Interferons)
p. 1187-1201
by ,  and
Pharmaceuticals 2010, 3(4), 1187-1201; doi:10.3390/ph3041187
Received: 16 March 2010; in revised form: 15 April 2010 / Accepted: 19 April 2010 / Published: 20 April 2010
Show/Hide Abstract | Cited by 2 | PDF Full-text (3648 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Non-Steroidal Anti-Inflammatory Drugs)
p. 1202-1224
by  and
Pharmaceuticals 2010, 3(4), 1202-1224; doi:10.3390/ph3041202
Received: 16 February 2010; in revised form: 25 March 2010 / Accepted: 29 March 2010 / Published: 20 April 2010
Show/Hide Abstract | Cited by 5 | PDF Full-text (312 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Targeted Therapy)
p. 1225-1231
by
Pharmaceuticals 2010, 3(4), 1225-1231; doi:10.3390/ph3041225
Received: 9 March 2010; in revised form: 21 April 2010 / Accepted: 22 April 2010 / Published: 22 April 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (169 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Protein Kinase Inhibitors)
p. 1241-1278
by , , ,  and
Pharmaceuticals 2010, 3(4), 1241-1278; doi:10.3390/ph3041241
Received: 14 February 2010; in revised form: 20 April 2010 / Accepted: 22 April 2010 / Published: 23 April 2010
Show/Hide Abstract | Cited by 6 | PDF Full-text (1390 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Angiogenesis Inhibitors)
abstract graphic
Select/unselect all
Displaying article 1-24
Select articles Export citation of selected articles as:
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert